NEW ARTICLE: IVERMECTIN Tested against 28 types of Cancer - which cancers were most sensitive to Ivermectin? Which were least sensitive?
A research group from Mexico investigated Ivermectin in Cancer
Paper: 2020 (Juarez et al) - Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug.
this paper is behind a paywall, not accessible to the general population
Ivermectin was tested at 2mg/kg/day which translates to roughly 5uM in vitro concentration
The most sensitive cancer cell lines were:
1. Ovarian
2. Breast
3. Glioblastoma
4. Lung Cancer
5. Colon Cancer
6. Uterine SCC
7. hepatocellular
8. breast TNBC
9. Pancreatic
10. Endometrial
Least sensitive were:
1. osteosarcoma
2. gastric
3. melanoma
Although lymphoma and leukemia cell lines appear to be more resistant to Ivermectin, Ivermectin has a significant impact on those cells' ability to form colonies.
So yes, Ivermectin is useful against BOTH lymphomas and leukemias...
No comments:
Post a Comment